Postenucleation Adjuvant Therapy in High-Risk Retinoblastoma

Abstract

Postenucleation adjuvant therapy is safe and effective in significantly reducing the occurrence of metastasis in patients with retinoblastoma manifesting histopathologic high-risk characteristics.